Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ari Melnick

Showing results (111-120 of 230) with videos related to

Pageof 23
Sort By:
Cancer Cell|December 26, 2017
Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor SensitivityHiroyoshi Kunimoto, Cem Meydan, Abbas Nazir, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 13, 2024
Profiling Dynamic Patterns of Single-Cell MotilityDebonil Maity, Nikita Sivakumar, Pratik Kamat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Outcome of deferred initial therapy in mantle-cell lymphomaPeter Martin, Amy Chadburn, Paul Christos, et al.
Blood|March 27, 2014
Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profilingErdogan Taskesen, Marije Havermans, Kirsten van Lom, et al.
The Journal of Clinical Investigation|February 4, 2014
HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemiaBoris Bartholdy, Maximilian Christopeit, Britta Will, et al.
Cell Reports|December 17, 2013
PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complexLy P Vu, Fabiana Perna, Lan Wang, et al.
Molecular and Cellular Biology|December 16, 2005
Kaiso-deficient mice show resistance to intestinal cancerAnna Prokhortchouk, Owen Sansom, Jim Selfridge, et al.
Nature Biotechnology|July 21, 2010
Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cellsJose M Polo, Susanna Liu, Maria Eugenia Figueroa, et al.
Blood|January 27, 2009
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid featuresMaria E Figueroa, Bas J Wouters, Lucy Skrabanek, et al.
Nature Medicine|December 8, 2009
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomasLeandro C Cerchietti, Eloisi C Lopes, Shao Ning Yang, et al.
Pageof 23

Showing results (111-120 of 230) with videos related to

Sort By:
Pageof 23
Cancer Cell|December 26, 2017
Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor SensitivityHiroyoshi Kunimoto, Cem Meydan, Abbas Nazir, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|August 13, 2024
Profiling Dynamic Patterns of Single-Cell MotilityDebonil Maity, Nikita Sivakumar, Pratik Kamat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2009
Outcome of deferred initial therapy in mantle-cell lymphomaPeter Martin, Amy Chadburn, Paul Christos, et al.
Blood|March 27, 2014
Two splice-factor mutant leukemia subgroups uncovered at the boundaries of MDS and AML using combined gene expression and DNA-methylation profilingErdogan Taskesen, Marije Havermans, Kirsten van Lom, et al.
The Journal of Clinical Investigation|February 4, 2014
HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemiaBoris Bartholdy, Maximilian Christopeit, Britta Will, et al.
Cell Reports|December 17, 2013
PRMT4 blocks myeloid differentiation by assembling a methyl-RUNX1-dependent repressor complexLy P Vu, Fabiana Perna, Lan Wang, et al.
Molecular and Cellular Biology|December 16, 2005
Kaiso-deficient mice show resistance to intestinal cancerAnna Prokhortchouk, Owen Sansom, Jim Selfridge, et al.
Nature Biotechnology|July 21, 2010
Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cellsJose M Polo, Susanna Liu, Maria Eugenia Figueroa, et al.
Blood|January 27, 2009
Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid featuresMaria E Figueroa, Bas J Wouters, Lucy Skrabanek, et al.
Nature Medicine|December 8, 2009
A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6-dependent B cell lymphomasLeandro C Cerchietti, Eloisi C Lopes, Shao Ning Yang, et al.
Pageof 23